IGF1 and Alzheimer disease: Rg5 improved cognitive dysfunction in an AD rat model by attenuating Aβ accumulation and increasing the expression of neurotrophic factors such as brain-derived neurotrophic factor (BDNF) and insulin-like growth factor 1 (IGF-1) [38].